companyprofile

Actions

Saudi Pharmaceutical Industries and Medical Appliances Corp.

2070
SPIMACO
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Pharma, Biotech & Life Science

Stats Overview

  • Prev. Close 23.00
  • Open -
  • High -
  • Low -
  • No. of Trades 0
  • Avg. Trade size* N/A
  • Volume Traded 0
  • Value Traded (SAR) 0.00

Performance

SPIMACO
0.00 ( - )
Compare
Index Name Index Level 1D Return
Saudi Pharmaceutical Industries and Medical Appliances Corp. 0.00 -
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
-
% Change
-
Volume Traded
0

Best Bid

Price 22.84
Volume Traded 2,450

Best Offer

Price 22.96
Volume Traded 61

52 WEEK

High
41.00
2022/02/20
Low
21.02
2022/12/20
Change**
0.0

PERFORMANCE

Start of Year
21.9
Year ago
39.9
3 Years ago
28.45

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the signing of a credit facility agreement (Sharia compliant) with Al-Rajhi Bank.

    2070
    SPIMACO 0.0 %
    1444/06/05     29/12/2022 08:03:45
  • Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the signing of a credit facility agreement (Sharia compliant) with SABB Bank.

    2070
    SPIMACO 0.0 %
    1444/06/05     29/12/2022 08:01:46
  • The Saudi Company for Pharmaceutical Industries and Medical Appliances announces the latest developments regarding the Company’s Tower in Al-Sahafa District

    2070
    SPIMACO 0.0 %
    1444/06/01     25/12/2022 08:02:37
  • SPIMACO Completes Its Strategic Review Plans and Rolls Out a Revamped 5-year Strategy

    2070
    SPIMACO 0.0 %
    1444/05/25     19/12/2022 08:12:29
  • Addendum Announcement from Saudi Pharmaceutical Industries and Medical Appliances Corp. in regards to The Saudi Company for Pharmaceutical Industries and Medical Supplies (SPIMACO Pharmaceutical) announces the inauguration of Oncology and High Potent Drugs Plant with a value of SAR 272 million.

    2070
    SPIMACO 0.0 %
    1444/04/23     17/11/2022 09:29:45
View All

Corporate Actions

--
All Corporate Actions

CompanyProfilev2Financials

Actions
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Financials

  • Balance Sheet
  • Statement of Income
  • Cash Flow
  • XBRL
  • Detailed Reports and Statements
  • Annually
  • Quarterly
Balance Sheet 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Current Assets
1,470,962
1,469,932
1,473,860
1,698,625
Inventory
419,093
458,060
401,462
480,094
Investments
630,974
823,961
918,279
944,333
Fixed Assets
1,816,582
1,830,730
1,713,282
1,404,303
Other Assets
96,463
100,107
117,036
240,181
Total Assets
4,434,074
4,682,790
4,623,919
4,767,536
Current Liabilities
1,637,062
1,567,491
1,414,019
1,020,017
Non-Current Liabilities
800,926
1,040,153
1,090,228
930,793
Other Liabilities
2,681
4,183
- -
Shareholders Equity
1,837,762
1,915,533
2,119,672
2,641,944
Total Liabilities and Shareholder Equity
4,434,074
4,682,790
4,623,919
4,767,536
Minority Interests
155,643
155,430
-
174,782
All Figures in Thousands Thousands Thousands Thousands
All Currency In SAR SAR SAR SAR
Last Update Date 2022-03-31 2021-03-30 2020-05-20 2019-03-11
Balance Sheet 2022-09-30 2022-06-30 2022-03-31 2021-09-30
Current Assets
1,692,647
1,981,451
1,598,070
1,612,805
Inventory
520,986
530,512
429,779
445,449
Investments
81,116
116,353
600,154
634,790
Fixed Assets
1,833,276
1,828,233
1,823,333
1,827,341
Other Assets
76,663
83,406
88,629
81,257
Total Assets
4,204,688
4,539,955
4,539,965
4,601,642
Current Liabilities
1,565,301
1,856,334
1,625,520
1,571,313
Non-Current Liabilities
793,015
791,258
895,777
1,015,244
Other Liabilities
80
53
2,148
242
Shareholders Equity
1,695,563
1,744,559
1,863,637
1,863,995
Total Liabilities and Shareholder Equity
4,204,688
4,539,955
4,539,965
4,601,642
Minority Interests
150,729
147,751
152,883
150,848
All Figures in Thousands Thousands Thousands Thousands
All Currency In SAR SAR SAR SAR
Last Update Date 2022-11-10 2022-08-24 2022-05-23 2021-11-14
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Shareholding Information

  • Board Of Directors
  • Foreign Ownership
  • Substantial Shareholders
Time Period
-
Search
Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
2023-02-05 مي عبدالله عبدالرحمن العجاجي Board of Directors 0.0000417 0.0000417 0
2023-02-05 عبدالرحمن محمد عبدالرحمن الثنيان Board of Directors 0.0014042 0.0014042 0
2023-02-05 عمار عبدالواحد فالح الخضيري Board of Directors 0.0008333 0.0008333 0
2023-02-05 خالد صالح فهد الخطاف Senior Executives 0.0158333 0.0158333 0
2023-02-05 فيصل محمد امين شاكر Board of Directors 0.0008333 0.0008333 0
2023-02-05 فهد عبدالعزيز محمد الربيعه Board of Directors 0.0225000 0.0225000 0
2023-02-05 خالد عبدالرحمن عبدالله القويز Board of Directors 0.0003392 0.0003392 0
  • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
for
subs
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Peer Comparison

  • Table
  • Graphical
Add Company

Compare Selected

Select a Maximum of 5 Companies

Company Apply
Saudi Pharmaceutical Industries and Medical Appliances Corp.
Price -
Market Cap (SAR MN) 2,760
P/E Ratio -25.34
Jump To:
  • Announcements & Corporate Actions
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Company Profile

Company overview

It was established in January 1986 with the main objective of setting up an advanced pharmaceutical industry in the Kingdom of Saudi Arabia, for the local production of pharmaceutical products and medical appliances and to market these products inside the Kingdom and abroad.

Company History

SPIMACO is a Saudi Joint-Stock Company with a fully paid up capital of SR 1,200,000,000

Company Bylaws

Click here

Equity Profile

  • Authorized Capital (SAR) 1,200,000,000
  • Issued Shares 120,000,000
  • Paid Capital (SAR) 1,200,000,000
  • Par Value/Share 10
  • Paid Up Value/Share 10

Last Update :2014-04-17

Investment limits

There are no investment limits on the company s shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company s bylaw and the issued instructions by the related regulators and supervisory authorities

 

  • Company Details
  • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
  • Date Established

    1986/01/20

  • Financial Year End

    31/12

  • Listing Date

    1994/01/01

  • External Auditors

    [Baker Tilly MKM & Co]

  • ISIN CODE

    SA0007879188

  • Number of Employees

    -

  • Chairman

    HE.Mohammed Talal Alnahas
    Non - Executive

    HE.Mohammed Talal Alnahas
    • BD Session Start
      2022-04-03
      Designation
      Chairman
    • BD Session End
      2025-04-02
      Classification
      Non - Executive
  • Board of Directors

    Mr. Ammar Abdulwahed Alkhudairy Deputy Chairman - Independent

    Mr. Ammar Abdulwahed Alkhudairy
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Deputy Chairman - Independent

    Eng. Adil Kareem kak Ahmed Non - Executive

    Eng. Adil Kareem kak Ahmed
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Non - Executive

    Dr.Mohammad Khalil Mohammad Mohammad Non - Executive

    Dr.Mohammad Khalil Mohammad Mohammad
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Non - Executive

    Mr. Faisal Mohammed Shaker Non - Executive

    Mr. Faisal Mohammed Shaker
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Non - Executive

    Mr. Khalid A. Algwaiz Independent

    Mr. Khalid A. Algwaiz
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Independent

    Mr.Abdulrhman Mohammed Al Thinyan Independent

    Mr.Abdulrhman Mohammed Al Thinyan
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Independent

    Dr.Mai Abullah Alajaji Independent

    Dr.Mai Abullah Alajaji
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Independent

    Dr.Fahad Abdulaziz Alrabiah Independent

    Dr.Fahad Abdulaziz Alrabiah
    • BD Session Start
      2022-04-03
      Designation
      Board of Directors
    • BD Session End
      2025-04-02
      Classification
      Independent
  • Senior Executives

    Mr.Khalid Saleh Alkhattaf CEO

    Mr.Khalid Saleh Alkhattaf
    • BD Session Start
      2021-01-05
      Designation
      Senior Executives
    • BD Session End
      -
      Classification
      CEO

    Dr.Michael Baum CFO

Dr.Michael Baum
  • BD Session Start
    2022-05-01
    Designation
    Senior Executives
  • BD Session End
    -
    Classification
    CFO

Investor Relations

Contact Name:

Investor Relations Department

Company Address:

Al-Qassim 2597 Buraydah- Riyad - 89 Ahsa street - Al-Zahra P.O.Box 20001 Riyadh 11455

Contact Details:

Telephone: +966 (11) 2523320
Fax: +966 (11) 2523300
Email: investor.relations@spimaco.sa

Company Website:

www.spimaco.com.sa


Add To Watchlist
In your Watchlist
Add To Watchlist